Clinical Trial Update: Varenicline (Champix®) Special Investigation (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

Pfizer completed a Special Investigation under a regulatory post-marketing commitment plan for varenicline (Champix) related to smoking cessation, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• Champix (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Status: COMPLETED | Results posted: 2015-02-11